1 OCTOBER 2014
IMPORTANT NOTIFICATION
Please be informed of the following Regarding Collection and Disposal of Medical Infectious Waste
Global laboratories (GCV labs) has obtained the necessary Regulatory documentation and approvals for removal of Infectious Medical Waste, in accordance with Local (Department of Health, S Africa) and International (IATA) requirements.
Kindly Please pay Attention to the following requirements:
GCV labs will provide waste containers with specific serial numbers which will be traceable to your facility
Upon arrival of the containers, please provide written acknowledgment of receipt
The waste container will be in your custody, until it is returned to GCVLabs, theft, risk, loss, usage during this time is the responsibility of the user.
The container will be collected upon request (usually when full), written proof of submission for disposal to GCV collectors must be provided. Containers will be assessed by the Medical waste disposal, the contents must meet all regulatory compliances eg Sharps containers for Sharps only , The lab will provide details if required.
There will be no cost implicated to you, the client
Trust this service is of benefit to your practice and we trust that the disposal facility will be used for GCV consumables
Thanking you, kindly
Dr Madurai –Director
Dr F Deedat – Chief Pathologist
Interesting Reading : 2014- GCV Peer Reviews Publications
1. J Int AIDS Soc. 2013; 16(1): 18744.
Published online 2013 November 14. doi: 10.7448/IAS.16.1.18744
PMCID: PMC3830054 Quality of home-based rapid HIV testing by community lay counsellors in a rural district of South Africa
Debra Jackson,§,1 Reshma Naik,2 Hanani Tabana,2 Mogiluxmi Pillay,3 Savathee Madurai,3 Wanga Zembe,2 and Tanya Doherty1,2
(3 GCV Labs)
2. Journal: Clinical Biochemistry
Title: Validation of method for analysis of Hemoglobin A1C from dried blood spots.
Corresponding Author: Sharon Williams
Co-Authors: Elizabeth A Thiele, Ph.D.; Lori J Fitton, Ph.D. ; Paul Kowal, Pharm. D. ; Someshni Nair; Savathree Madurai; James J Snodgrass, Phd, in press
3. Evaluation of the NucliSens EasyQ v2.0 Assay in Comparison with the Roche Amplicor v1.5 and the Roche CAP/CTM HIV-1 Test v2.0 in Quantification of C-Clade HIV-1 in Plasma
Maximilian Muenchhoff1,2, Savathee Madurai3, Allison Jo Hempenstall1, Emily Adland1, Anna Carlqvist1, Angeline Moonsamy2, Manjeetha Jaggernath2, Busisiwe Mlotshwa2, Emma Siboto2, Thumbi Ndung’u2,4,5,6, Philip Jeremy Renshaw Goulder1,2,6*
1 Department of Paediatrics, University of Oxford, Oxford, Oxfordshire, United Kingdom, 2 HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa, 3 Global Clinical and Viral Laboratories, Amanzimtoti, KwaZulu-Natal, South Africa, 4 KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), University of KwaZulu-Natal, Durban, South Africa, 5 Max Planck Institute for Infection Biology, Berlin, Berlin, Germany, 6 The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, Massachusetts, United States of America